| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 01/08/2004 | WO2002053596A3 Antibodies to insulin-like growth factor i receptor |
| 01/08/2004 | US20040006781 Method of constructing heart failure model animal |
| 01/08/2004 | US20040006129 Administering compound selected from 4,4'-(isopropylidenedithio) bis(2,6-di-tert-butylphenol), 2,3-Dihydro-5-hydroxy-2 2-dipentyl-4,6-di-tert-butyl-benzofuran, vitamin E and vitamin c |
| 01/08/2004 | US20040006113 Methods for nicotine replacement dosage determination |
| 01/08/2004 | US20040005649 Monoclonal antibody for monitoring and treating changes in tumor growth or metastasis |
| 01/08/2004 | US20040005643 Anti-human tenascin monoclonal antibody |
| 01/08/2004 | US20040005641 Identifying compounds which enhance efficacy and transfer of therapeutic agents; drug delivery; for treating blood, respiratory, tumor and metabolic disorders |
| 01/08/2004 | US20040005274 Targeting multimeric imaging agents through multilocus binding |
| 01/08/2004 | DE10225932A1 Bildgebendes Verfahren und Vorrichtung zu dessen Durchführung Imaging method and device for its implementation |
| 01/08/2004 | CA2492080A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 01/08/2004 | CA2490411A1 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 01/08/2004 | CA2490285A1 Methods and contrast agents useful in quantifying nitric oxide |
| 01/08/2004 | CA2489555A1 Camptothecin-carboxylate formulations |
| 01/08/2004 | CA2488039A1 A pharmaceutical composition for preventive and/or therapeutic treatment of constipation and symptom resulting from constipation |
| 01/07/2004 | EP1378524A2 Recombinant thrombin receptor antibodies and their use |
| 01/07/2004 | EP1378239A1 Contrast agents for imaging |
| 01/07/2004 | EP1377321A2 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 01/07/2004 | EP1377311A2 Treatment of neuropathologies associated with expression of tnf-alpha |
| 01/07/2004 | EP1377221A1 Method for viewing tumor tissue located within a body cavity |
| 01/07/2004 | EP1377220A1 Fluorescent cobalamins and uses thereof |
| 01/07/2004 | CN1465348A Compound ablation mixture and application in preparing medicine for treating tumor |
| 01/06/2004 | US6673768 Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) |
| 01/06/2004 | US6673574 Oral delivery of peptides using enzyme-cleavable membrane translocators |
| 01/06/2004 | US6673558 Drug compositions to prevent desensitization of cellular receptors |
| 01/06/2004 | US6673355 Administering vaccine to pregnant women; prevention and diagnosis of gastroenteritis, cystic fibrosis, and diarrhea |
| 01/06/2004 | US6673334 Light sensitive compounds for instant determination of organ function |
| 01/06/2004 | US6673333 Functional MRI agents for cancer imaging |
| 01/06/2004 | CA2096109C Tissue factor based prothrombin time reagent |
| 01/06/2004 | CA2047721C Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma |
| 01/02/2004 | EP1376125A1 Radiolabeled photosensitisers for use in cancer screening |
| 01/02/2004 | EP1375519A2 Method for affecting cellular function using antibodies |
| 01/02/2004 | EP1374913A1 Nontherapeutic process for evaluating cutaneous neurosensitivity, corresponding kit and its use |
| 01/02/2004 | EP1374912A1 Use of metaloporphyrins for treatment of arteriosclerotic lesions |
| 01/02/2004 | EP1374911A1 Agents for measuring pyrimidine metabolizability |
| 01/02/2004 | EP1374897A1 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates |
| 01/02/2004 | EP1374777A1 Ultrasonic diagnostic imaging with contrast agents |
| 01/02/2004 | EP1372742A2 Polymeric imagable brachytherapy seed |
| 01/02/2004 | EP1372741A2 Morpholino imaging and therapy |
| 01/02/2004 | EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/02/2004 | EP1372738A1 Increasing retrievable fluid from a breast duct |
| 01/02/2004 | EP1372737A2 Preparation for the prophylaxis of restenosis |
| 01/02/2004 | EP1372718A2 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 01/02/2004 | EP1372694A1 Liposome targeting of matrix metalloproteinase inhibitors |
| 01/02/2004 | EP1372648A2 Tie2 receptor kinase inhibitors for treating angiogenic diseases |
| 01/02/2004 | EP1372633A1 Irrigating fluid |
| 01/02/2004 | EP1372626A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 01/02/2004 | EP1372625A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors |
| 01/02/2004 | EP1372553A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 01/02/2004 | EP0979103B1 Light imaging contrast agents |
| 01/01/2004 | US20040003423 Transgenic knockout animal model null for pigment epithelium-derived factor (PEDF) |
| 01/01/2004 | US20040001894 Mixture of radioopacity material in carrier |
| 01/01/2004 | US20040001841 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 12/31/2003 | WO2004001409A2 Method for screening modulators of the transmission of immunity |
| 12/31/2003 | WO2004000308A1 Method of photodynamic diagnosis for vascular diseases |
| 12/31/2003 | WO2003087302A3 Dual-labeled nucleotides |
| 12/31/2003 | WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 12/31/2003 | WO2003061621A3 Dermal application system for aminolevulinic acid-derivatives |
| 12/31/2003 | WO2002080756A3 Imaging systems for in vivo protocols |
| 12/31/2003 | WO2002072155A3 Use of sydnonimines for specific diagnoses of erectile dysfunctions |
| 12/31/2003 | WO2002040671A3 Immunoglobulin superfamily proteins |
| 12/31/2003 | WO2002040060A3 Conjugates of an antioxidants with metal chelating ligands |
| 12/31/2003 | CN1132822C Metal chelates of substituted polyaminocarboxylic macrocycles and their use in diagnostic imaging |
| 12/30/2003 | US6670140 Determining whether test compound binds to receptor, selecting compound that binds, determining whether compound increases muscle mass or function in skeletal muscle atrophy model system, identifying compound that modulates mass or function |
| 12/30/2003 | US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties |
| 12/30/2003 | US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes |
| 12/30/2003 | US6669938 ImmunoConjucates for cancer diagnosis and therapy |
| 12/30/2003 | US6669926 Hydrophilic light absorbing indole compounds for determination of physiological function in critically ill patients |
| 12/25/2003 | WO2003106495A2 MONOCLONAL ANTIBODY hPAM4 |
| 12/25/2003 | US20030236457 Method of endovascular brain mapping |
| 12/25/2003 | US20030236417 A 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid or ester derivatives, use as iron metabolic chelators in therapeutic applications; demetallization |
| 12/25/2003 | US20030236407 Perfluoroalkyl group-containing micelle-forming triiodoaromatic compounds, process for their production and their use as contrast media |
| 12/25/2003 | US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 12/25/2003 | US20030235813 In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selecting cell populations for autologous transplantation |
| 12/25/2003 | US20030235535 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions |
| 12/25/2003 | US20030235531 Method of using metaloporphyrins for treatment of arteriosclerotic lesions |
| 12/24/2003 | WO2003106685A1 Cell wall mutants for delivery of biologically active compounds |
| 12/24/2003 | WO2003106667A2 Regulation of human subtilase-like serine protease |
| 12/24/2003 | WO2003106627A2 Cancer-linked gene as target for chemotherapy |
| 12/24/2003 | WO2003106498A2 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | WO2003105814A1 In vivo imaging of apoptosis |
| 12/24/2003 | WO2003105694A1 Temporary tattoo for testing the sensitivity of skin to chemicals |
| 12/24/2003 | WO2003072755A3 Transgenic zebrafish models for thrombosis |
| 12/24/2003 | WO2003072558A3 Arylsulfone derivatives |
| 12/24/2003 | WO2003072548A8 Pyridyl sulfone derivatives as 5-ht receptor antagonists |
| 12/24/2003 | WO2003033709A3 Regulation of human serine/threonine protein kinase |
| 12/24/2003 | WO2003032900A3 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | WO2002102825A3 Fluorescently labelled locked nucleic acids |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | CA2492685A1 Cell wall mutants for delivery of biologically active compounds |
| 12/24/2003 | CA2489467A1 Humanized monoclonal antibody hpam4 |
| 12/24/2003 | CA2489004A1 Agonistic binding molecules to the human ox40 receptor |
| 12/24/2003 | CA2488705A1 A nanoporous particle with a retained target |
| 12/24/2003 | CA2488643A1 Coated particles, methods of making and using |
| 12/24/2003 | CA2487516A1 Temporary tattoo for testing the sensitivity of skin to chemicals |
| 12/24/2003 | CA2479938A1 In vivo imaging of apoptosis |
| 12/23/2003 | US6667008 Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 12/21/2003 | CA2432777A1 Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques |
| 12/20/2003 | CA2424443A1 Chlorin and bacteriochlorin-based difunctional aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals |
| 12/18/2003 | WO2003104799A2 Imaging method and device for carrying out said method |